Skip to main content

Molecular Imaging and Therapy

The Molecular Imaging and Therapy research group focuses its activity on deepening the molecular bases and developing new areas of research in molecular signaling pathways and the identification of new theranostic targets.

We promote the confluence of basic and clinical researchers, experts in imaging and molecular biology to provide:

  • Access to knowledge of the biokinetics and biodistribution of the molecules under study
  • The proofs of concept necessary in the research processes
  • The identification and quantification of the targets defined by the research groups of our center

In this context, the creation of a translational imaging unit constitutes a basic objective for the development of research aimed at the personalized treatment of patients.

The group is made up of medical specialists in molecular imaging, chemists and pharmacists specializing in tracer synthesis, and biomedical engineers and physicists specializing in image processing and tomography equipment. These are affiliated with different institutions, such as the Vall d'Hebron Research Institute (VHIR), the Vall d'Hebron University Hospital (HUVH) and the Institute of Diagnostic Imaging (IDI).

Team

Sergio Lopez Gandul

Sergio Lopez Gandul

Molecular Imaging and Therapy
Read more
Susana  Garcia  Bayona

Susana Garcia Bayona

Molecular Imaging and Therapy
Read more
Sergio Lopez Gandul

Sergio Lopez Gandul

Molecular Imaging and Therapy
Read more
Susana  Garcia  Bayona

Susana Garcia Bayona

Molecular Imaging and Therapy
Read more
Blog

News

Researchers from the centre took part in international debates on AI in healthcare, spin-offs emerging from research were presented, and several initiatives linked to VHIR received recognition in the field of entrepreneurship.

ImmunoPET enables in vivo detection of LIF expression, a molecule linked to tumour growth, immune evasion and treatment resistance.

UNCAN-Connect aims to enhance interoperability and accelerate scientific progress by supporting open science and strengthening collaborations.